Acorda Therapeutics Inc Precio/Ventas
¿Qué es el Precio/Ventas de Acorda Therapeutics Inc?
El Precio/Ventas de Acorda Therapeutics Inc es 0.11
¿Cuál es la definición de Precio/Ventas?
El ratio precio / ventas es el precio de las acciones de una empresa en comparación con sus ingresos.
The price to sales ratio, Price/Sales ratio, P/S ratio, or PSR, is a valuation metric for stocks. It is calculated by dividing the company's market cap by the revenue in the most recent year. It can also be calculated by dividing the per-share stock price by per-share revenue. The price to sales ratio is for trailing twelve months so the reported sales are for the four previous quarters. Longer time periods can be examined at times.
A smaller price to sales ratio is usually thought to be a better investment since the investor is paying less for each unit of sales. However, sales do not reveal the whole picture, as the company may be unprofitable with a low P/S ratio. Because of the limitations, this ratio is usually used only for unprofitable companies, since they don't have a price to earnings ratio (P/E ratio). The metric can be used to determine the value of a stock relative to its past performance. It may also be used to determine relative valuation of a sector or the market as a whole.
Price to sales ratios vary greatly between sectors, so they are most useful in comparing similar stocks within a sector or sub-sector. Comparing P/S ratios carries the implicit assumption that all firms in the comparison have an identical capital structure.
Precio/Ventas de compañías en Sector Health Care en NASDAQ en comparadas con Acorda Therapeutics Inc
¿Qué hace Acorda Therapeutics Inc?
acorda therapeutics is a publicly traded (nasdaq: acor) biotechnology company whose mission is to develop therapies that restore neurological function and improve the lives of people with neurological disorders. we started our company in 1995 as a network of scientists, physicians and business people with a common belief that sharing ideas and information could lead to innovative medical advances for people with neurological disorders. we have since evolved into a commercial-stage biotechnology company, successfully developing and commercializing important therapies that advance the care of people affected by neurological conditions. we achieve our goals by: • investing in research and development • collaborating closely with the patient, medical and scientific communities • retaining employees with compassion and commitment acorda has been voted one of the best companies to work for in new york for the past five years in a row, as a result of our dynamic environment, strong corporate
Empresas con precio/ventas similar a Acorda Therapeutics Inc
- Sakuma Exports tiene Precio/Ventas de 0.11
- ATOS SE tiene Precio/Ventas de 0.11
- BRF S.A tiene Precio/Ventas de 0.11
- Guan Chao tiene Precio/Ventas de 0.11
- TCL Electronics tiene Precio/Ventas de 0.11
- TClarke Plc tiene Precio/Ventas de 0.11
- Acorda Therapeutics Inc tiene Precio/Ventas de 0.11
- Sintex Industries tiene Precio/Ventas de 0.11
- Kisan Mouldings tiene Precio/Ventas de 0.11
- EVRAZ Plc tiene Precio/Ventas de 0.11
- Transtech Optelecom Science tiene Precio/Ventas de 0.11
- ParcelPal Technology tiene Precio/Ventas de 0.11
- Hong Kong Johnson Hldg Co Ltd tiene Precio/Ventas de 0.11